Your browser doesn't support javascript.
loading
Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer.
Entrialgo-Cadierno, Rodrigo; Cueto-Ureña, Cristina; Welch, Connor; Feliu, Iker; Macaya, Irati; Vera, Laura; Morales, Xabier; Michelina, Sandra Vietti; Scaparone, Pietro; Lopez, Ines; Darbo, Elodie; Erice, Oihane; Vallejo, Adrian; Moreno, Haritz; Goñi-Salaverri, Ainhoa; Lara-Astiaso, David; Halberg, Nils; Cortes-Dominguez, Ivan; Guruceaga, Elizabeth; Ambrogio, Chiara; Lecanda, Fernando; Vicent, Silve.
Affiliation
  • Entrialgo-Cadierno R; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.
  • Cueto-Ureña C; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.
  • Welch C; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.
  • Feliu I; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.
  • Macaya I; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.
  • Vera L; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.
  • Morales X; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.
  • Michelina SV; Imaging Unit and Cancer Imaging Laboratory, University of Navarra, CIMA, Pamplona, Spain.
  • Scaparone P; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Torino, Turin, Italy.
  • Lopez I; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Torino, Turin, Italy.
  • Darbo E; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.
  • Erice O; University of Bordeaux, INSERM, BRIC, Bordeaux, 1312, F­33000, France.
  • Vallejo A; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.
  • Moreno H; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.
  • Goñi-Salaverri A; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.
  • Lara-Astiaso D; Molecular Therapies Program, University of Navarra, CIMA, Pamplona, Spain.
  • Halberg N; Molecular Therapies Program, University of Navarra, CIMA, Pamplona, Spain.
  • Cortes-Dominguez I; Wellcome - MRC Cambridge Stem Cell Institute (CSCI), Cambridge, UK.
  • Guruceaga E; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Ambrogio C; Imaging Unit and Cancer Imaging Laboratory, University of Navarra, CIMA, Pamplona, Spain.
  • Lecanda F; Bioinformatics Platform, University of Navarra, CIMA, Pamplona, Spain.
  • Vicent S; Bioinformatics Platform, University of Navarra, CIMA, Pamplona, Spain.
Mol Cancer ; 22(1): 97, 2023 Jun 16.
Article in En | MEDLINE | ID: mdl-37328838
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: España